[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.205.0.26. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Medical News & Perspectives
August 26, 1998

Drug Firm Suit Fails to Halt Publication of Canadian Health Technology Report

Author Affiliations
 

Not Available

Not Available

JAMA. 1998;280(8):683-684. doi:10.1001/jama.280.8.683-JMN0826-2-1

A CANADIAN appeals court has upheld a lower court's decision denying a pharmaceutical company's motion to block publication of a health technology report that the company contends may damage its commercial interests.

In December 1997, Bristol-Myers Squibb Canada Inc sued the Canadian Coordinating Office of Health Technology Assessment (CCOHTA) to prevent the release of its summary report on cholesterol-lowering statin drugs. The company contends that the report contains "negligent misstatements" that could negatively affect the sale of its drug Pravachol (pravastatin).

First Page Preview View Large
First page PDF preview
First page PDF preview
×